Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Life Sciences and Healthcare
April 10, 2017
Academia and Government
April 7, 2017
Life Sciences and Healthcare
March 31, 2017
Life Sciences and Healthcare
March 30, 2017
Life Sciences and Healthcare
March 30, 2017
Life Sciences and Healthcare
March 30, 2017
Academia and Government
March 28, 2017
Academia and Government
March 28, 2017